vTv Therapeutics Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.98M1.55M0.52M0.63M0.29M12.43M2.76M6.41M4.00M2.02M0.09M1.02M
Gross Profit 0.98M1.55M0.52M0.63M0.29M12.43M2.76M6.41M4.00M2.02M0.09M1.02M
Operating items
Research & Development 22.29M17.38M27.24M44.95M39.64M23.04M15.12M11.02M13.32M12.36M13.60M11.55M
Selling, General & Administrative 11.38M11.72M9.08M9.91M11.33M9.22M8.54M7.25M12.34M12.20M11.91M13.65M
Other Operating Expenses 3.14M1.35M2.35M0.80M
Operating Expenses 36.81M30.45M38.66M55.65M50.97M32.26M23.66M18.27M25.67M24.56M25.50M25.20M
Operating Income -35.83M-28.90M-38.14M-55.02M-50.68M-19.82M-20.89M-11.85M-21.66M-22.54M-25.50M-24.18M
EBIT -35.83M-28.90M-38.14M-55.02M-50.68M-19.82M-20.89M-11.85M-21.66M-22.54M-25.50M-24.18M
Non-operating items
Interest & Investment Income 0.00M0.04M0.09M0.12M0.06M0.05M0.01M0.00M0.35M0.47M1.56M
Other Non Operating Income 0.04M-0.50M-0.84M-0.02M0.05M0.00M2.45M-3.62M-1.50M0.16M
Non Operating Income 0.04M-0.50M-0.84M-0.02M0.05M0.00M2.45M-3.62M-1.50M0.16M
Net income details
EBT -48.20M-36.10M-41.11M-55.35M-53.85M-23.64M-21.84M-12.80M-17.62M-24.87M-25.97M-22.61M
Tax Provisions 0.80M0.20M0.10M0.12M0.20M0.10M
Profit After Tax -48.20M-36.10M-41.11M-55.35M-54.65M-23.84M-21.94M-12.80M-17.73M-25.07M-25.97M-22.70M
Income from Non-Controlling Interests -13.61M-39.00M-38.50M-15.93M-8.89M-4.30M-4.74M-5.91M-5.72M-4.24M
Income from Continuing Operations -48.20M-36.10M-41.11M-55.35M-54.65M-23.84M-21.94M-12.80M-17.73M-25.07M-25.97M-22.70M
Consolidated Net Income -48.20M-36.10M-41.11M-55.35M-54.65M-23.84M-21.94M-12.80M-17.73M-25.07M-25.97M-22.70M
Income towards Parent Company -48.20M-36.10M-41.11M-55.35M-54.65M-23.84M-21.94M-12.80M-17.73M-25.07M-25.97M-22.70M
Net Income towards Common Stockholders -48.20M-36.10M-41.11M-55.35M-16.14M-8.65M-17.91M-8.50M-12.99M-19.16M-20.25M-18.46M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.82M0.82M0.82M1.02M1.50M1.85M2.25M2.61M2.61M3.19M
Shares Outstanding (Diluted Average) 47.14M1.57M1.92M2.08M5.77M
EBITDA -35.83M-28.90M-38.14M-55.02M-50.68M-19.82M-20.89M-11.85M-21.66M-22.54M-25.50M-24.18M